PDCD1 and lung carcinoma: To experimentally demonstrate the cytolytic activation/proliferation of “dormant” TILs upon PD-1 axis blockade, we engrafted surgically resected primary lung cancer explants subcutaneously in immune deficient mice and administered intraperitoneally anti-PD-1 monoclonal antibodies.